Earnings Review

Earnings Reviews of some of the companies in The Octopus Portfolio

News & Trending TopicsTheon InternationalPandoraThe Octopus toolboxLonza Group AGIntroductionMiscellaneousThe Octopus PortfolioColoplast A/SSectors in briefInvestment pillsSchott Pharma AGJeronimo MartinsEarnings ReviewNovo Nordisk
Schott Pharma AGSchott Pharma AG
+1+1
Schott Pharma AG - H1 Earnings Review

Schott Pharma AG - H1 Earnings Review

The Tide is Finally Turning, at Last.

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
+1+1
Pandora A/S - Q1 2025 Earnings Review

Pandora A/S - Q1 2025 Earnings Review

How is the Affordable Jewelry Giant Doing during the Luxury Sector Backdrop?

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk - Q1 2025 Earnings Review

Novo Nordisk - Q1 2025 Earnings Review

When Expectations Are So Low...

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
+1+1
Pandora A/S - 2024 Earnings Review

Pandora A/S - 2024 Earnings Review

Another Year Surpassing the Expectations Set

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk A/S - 2024 Earnings Review

Novo Nordisk A/S - 2024 Earnings Review

When Expectations Are So Low Tha

The Octopus Value Investing
The Octopus Value Investing
Lonza Group AGLonza Group AG
+1+1
Lonza Group AG - 2024 Earnings Review

Lonza Group AG - 2024 Earnings Review

Lonza Group AG: Resilient Performance Amid Strategic Investments and Cost Discipline

The Octopus Value Investing
The Octopus Value Investing
Schott Pharma AGSchott Pharma AG
+1+1
Schott Pharma AG - 23/24 Earnings Review

Schott Pharma AG - 23/24 Earnings Review

Short-Term Fears Taking over a Earnings Report Within Expectations

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
+3+3
Q3 2024 Earnings Recap

Q3 2024 Earnings Recap

Earnings Review Compilation of Novo Nordisk, Pandora & Lonza AG

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
+1+1
Pandora A/S - H1 2024 Earnings Review

Pandora A/S - H1 2024 Earnings Review

The affordable luxury market defies pure luxury slowdown

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk - H1 2024 Earnings review

Novo Nordisk - H1 2024 Earnings review

More leader in the GLP-1 space than ever

The Octopus Value Investing
The Octopus Value Investing
Lonza Group AGLonza Group AG
+1+1
Lonza Group AG - H1 2024 Earnings Review

Lonza Group AG - H1 2024 Earnings Review

CDMO Giant Earnings within Expectations

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
Novo Nordisk - Q1 2024 Earnings review

Novo Nordisk - Q1 2024 Earnings review

A quick review on the reported earnings

The Octopus Value Investing
The Octopus Value Investing